GlassScriptPhysician profile
William L Case
NPI 1235161498
$2,012.32
in general payments reported to CMS, 2019-2025
20 companies · $915 in 2025
The $915 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.27 · 2020: $67.84 · 2021: $271 · 2022: $30.21 · 2023: $156 · 2024: $503 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,573.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $879.24 | 2019-2025 | Linzess, Viberzi, Rinvoq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $202.10 | 2019-2025 | Trulance, Xifaxan, Relistor |
| Takeda Pharmaceuticals U.S.A., INC. | $148.93 | 2019-2025 | Entyvio |
| Madrigal Pharmaceuticals | $139.92 | 2025 | Rezdiffra |
| Aimmune Therapeutics, INC. | $97.85 | 2024-2025 | Zenpep, Vowst |
| Phathom Pharmaceuticals, INC. | $67.70 | 2025 | Voquezna |
| Evoke Pharma, INC. | $64.23 | 2024-2025 | |
| Ardelyx, INC. | $54.80 | 2024-2025 | Ibsrela |
| Lilly USA, LLC | $49.39 | 2023-2024 | Omvoh |
| Gilead Sciences, INC. | $49.07 | 2023-2025 | |
| Janssen Biotech, INC. | $47.94 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $38.20 | 2025 | Dupixent |
| Celgene Corporation | $30.21 | 2022 | |
| Braintree Laboratories, INC. | $24.73 | 2024 | Suflave |
| Merck Sharp & Dohme LLC | $24.00 | 2024 | Dificid |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $22.51 | 2025 | Gastrointestinal Videoscope |
| Intercept Pharmaceuticals, INC. | $19.58 | 2024 | |
| Ironwood Pharmaceuticals, INC | $19.46 | 2023 | Linzess |
| Exact Sciences Corporation | $18.53 | 2025 | Cologuard Collection Kit |
| Shire North American Group INC | $13.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.